PHK
KDNY

Point72 Hong Kong’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Point72 Hong Kong’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,911
Closed -$33K – 2543
2022
Q2 		$33K Buy
+1,911
New +$30K ﹤0.01% 1454
2021
Q3 		– Sell
-124
Closed -$2K – 2562
2021
Q2 		$2K Buy
+124
New +$1.98K ﹤0.01% 1843
2018
Q1 		– Sell
-95
Closed -$4K – 1217
2017
Q4 		$4K Buy
95
+73
+332% +$3.19K ﹤0.01% 631
2017
Q3 		$1K Buy
+22
New +$1.31K ﹤0.01% 739

Other funds holding KDNY

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Point72 Hong Kong's KDNY Position: Q3 2022 in Review

Point72 Hong Kong sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2022, closing a stake of 1,911 shares — an estimated $33K sold.

Point72 Hong Kong first reported a position in KDNY in Q3 2017 and held it in 4 quarters. The position peaked at $33K in Q2 2022. 151 funds tracked by Wall St. Rank hold KDNY as of Q3 2022.

  • Point72 Hong Kong reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,911 Chinook Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $33K.
  • Point72 Hong Kong first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
  • Point72 Hong Kong's Chinook Therapeutics, Inc. Common Stock position peaked at $33K in Q2 2022.
  • 151 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.